Morgan Stanley raised the firm’s price target on Welltower (WELL) to $200 from $170 and keeps an Overweight rating on the shares. After examining Q3 results as well as supply/demand fundamentals in senior housing, the firm says it has higher conviction in Welltower and American Healthcare REIT’s (AHR) ability to execute on margin upside.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WELL:
- Welltower price target raised to $260 from $246 at BofA
- Welltower price target raised to $214 from $182 at Scotiabank
- GILD, COF, WELL: Top 3 Stocks to Buy Today, Backed by Technical Analysis
- Welltower upgraded to Outperform from In Line at Evercore ISI
- Welltower price target raised to $200 from $195 at Cantor Fitzgerald